These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3362859)

  • 1. Frequent generation of oncogenes by in vitro recombination of TRK protooncogene sequences.
    Oskam R; Coulier F; Ernst M; Martin-Zanca D; Barbacid M
    Proc Natl Acad Sci U S A; 1988 May; 85(9):2964-8. PubMed ID: 3362859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain.
    Coulier F; Kumar R; Ernst M; Klein R; Martin-Zanca D; Barbacid M
    Mol Cell Biol; 1990 Aug; 10(8):4202-10. PubMed ID: 1695324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F; Klein R; Barbacid M
    Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of conserved residues in the tyrosine kinase domain of the human trk oncogene.
    Mitra G
    Oncogene; 1991 Dec; 6(12):2237-41. PubMed ID: 1837350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene.
    Mitra G; Martin-Zanca D; Barbacid M
    Proc Natl Acad Sci U S A; 1987 Oct; 84(19):6707-11. PubMed ID: 3477801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of activation of the human trk oncogene.
    Coulier F; Martin-Zanca D; Ernst M; Barbacid M
    Mol Cell Biol; 1989 Jan; 9(1):15-23. PubMed ID: 2538716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and biochemical characterization of the human trk proto-oncogene.
    Martin-Zanca D; Oskam R; Mitra G; Copeland T; Barbacid M
    Mol Cell Biol; 1989 Jan; 9(1):24-33. PubMed ID: 2927393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the receptor kinase domain of the trk oncogene by recombination with two different cellular sequences.
    Kozma SC; Redmond SM; Fu XC; Saurer SM; Groner B; Hynes NE
    EMBO J; 1988 Jan; 7(1):147-54. PubMed ID: 2966065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic activation of the human trk proto-oncogene by recombination with the ribosomal large subunit protein L7a.
    Ziemiecki A; Müller RG; Fu XC; Hynes NE; Kozma S
    EMBO J; 1990 Jan; 9(1):191-6. PubMed ID: 2403926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.
    Tapley P; Lamballe F; Barbacid M
    Oncogene; 1992 Feb; 7(2):371-81. PubMed ID: 1312698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor.
    Meakin SO; Suter U; Drinkwater CC; Welcher AA; Shooter EM
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2374-8. PubMed ID: 1312719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trk oncogene abrogates growth factor requirements and transforms hematopoietic cells.
    Katzav S; Martin-Zanca D; Barbacid M; Hedge AM; Isfort R; Ihle JN
    Oncogene; 1989 Sep; 4(9):1129-35. PubMed ID: 2674855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of human trk proto-oncogene product monoclonal antibodies.
    Eager KB
    Oncogene; 1991 May; 6(5):819-24. PubMed ID: 2052359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of human TRK proto-oncogene into mouse cells using an inducible vector system.
    Mulherkar R; Coulier F
    Biochem Biophys Res Commun; 1991 May; 177(1):90-6. PubMed ID: 1645965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquisition of transforming properties by FYN, a normal SRC-related human gene.
    Kawakami T; Kawakami Y; Aaronson SA; Robbins KC
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):3870-4. PubMed ID: 3287380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of STAT3 in in vitro transformation triggered by TRK oncogenes.
    Miranda C; Fumagalli T; Anania MC; Vizioli MG; Pagliardini S; Pierotti MA; Greco A
    PLoS One; 2010 Mar; 5(3):e9446. PubMed ID: 20209132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific expression of the human tropomyosin gene involved in the generation of the trk oncogene.
    Reinach FC; MacLeod AR
    Nature; 1986 Aug 14-20; 322(6080):648-50. PubMed ID: 3018581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.